thrombectomy - search results
If you're not happy with the results, please do another search
PERT, AI and the rise of thrombectomy devices: ‘PERT leads to more advanced thrombectomy...
The increasing sophistication of the device space for the treatment of pulmonary embolism (PE) aligned with advances in the deployment of pulmonary embolism response...
Medtronic announces first commercial use of Liberant thrombectomy system
Medtronic has announced the first commercial use of its Liberant thrombectomy system, which is indicated for the removal of fresh, soft emboli or thrombi...
InterVene receives US FDA 510(k) clearance for Recana thrombectomy system
InterVene recently announced it has received 510(k) clearance from the US Food and Drug Administration (FDA) for the Recana thrombectomy catheter system, which is...
Mechanical thrombectomy system for AV access shows promise, study shows
A retrospective analysis of 64 patients treated between 2022 and 2025 using a novel mechanical thrombectomy system to treat dialysis access thrombus showed function...
STORM-PE finds mechanical thrombectomy superior to anticoagulation alone
The use of mechanical thrombectomy, specifically computer-assisted vacuum thrombectomy (CAVT) using the 16Fr Lightning Flash system (Penumbra), with anticoagulation achieves superior reduction in right...
When to re-intervene: Stent surveillance and the effective use of RevCore mechanical thrombectomy to...
This advertorial is sponsored by Stryker/Inari Medical.
How a finely tuned stent surveillance program plays a crucial role in raising the alarm of worsening symptoms...
Imperative Care announces FDA clearance for Symphony thrombectomy system
Imperative Care has today announced Food and Drug Administration (FDA) 510(k) clearance of its Symphony thrombectomy system to treat pulmonary embolism (PE).
This clearance expands...
Inari Medical, now part of Stryker, launches InThrill thrombectomy system
Inari Medical—now part of Stryker—has announced the launch of its next-generation InThrill thrombectomy system.
The company stated in a recent press release that this is...
First patient treated with InterVene’s Recana thrombectomy catheter system
InterVene announced today that the first patient has been treated with its Recana thrombectomy catheter system for venous in-stent restenosis (ISR).
The company shares...
Aventus thrombectomy system gains FDA clearance for PE treatment
Inquis Medical has announced that its Aventus thrombectomy system has received 510(k) clearance from the US Food and Drug Administration (FDA) for an expanded...
Inquis Medical’s Aventus thrombectomy system found safe and effective for patients with PE
Inquis Medical recently announced results from its AVENTUS trial evaluating the safety and efficacy of the company’s Aventus thrombectomy system.
The results were presented by...
Acute limb ischemia: Enhancing limb salvage rates with computer-assisted vacuum thrombectomy
This advertorial is sponsored by Penumbra, Inc.
Daniel Clair, MD, reflects on the STRIDE study of 30-day outcomes in patients who undergo first-line use of...
Surmodics announces commercial release of Pounce XL thrombectomy system
Surmodics has announced the commercial release of the Pounce XL thrombectomy system for endovascular removal of acute or chronic clot from peripheral arteries.
Intended for removal...
Imperative Care expands Symphony thrombectomy portfolio with new FDA approval
Imperative Care today announced Food and Drug Administration (FDA) 510(k) clearance of the 82cm version of its Symphony 16F catheter, the company’s latest innovation...
Novel thrombectomy system for VTE used successfully in first tranche of first-in-human cases
SonoVascular has announced the successful completion of an initial set of eight deep vein thrombosis (DVT) cases using its SonoThrombectomy system as part of...
Inari Medical, now part of Stryker, launches Artix thrombectomy system
Inari Medical, now part of Stryker, recently announced the launch of its Artix thrombectomy system. Purpose-built for the needs of the peripheral arterial system,...
New analysis details learning curve effect behind ‘significant improvement’ in performance of PE mechanical...
A multisite hospital system analysis of the safety and procedural learning curve behind the performance of percutaneous mechanical thrombectomy for pulmonary embolism (PE) shows...
How the RevCore and VenaCore thrombectomy catheters combine to broaden treatment approach among advanced...
This advertorial is sponsored by Inari Medical.
For Joseph M. Liechty, MD, a vascular surgeon with Texas Vascular Associates in Plano, Texas, the emergence of...
Tackling difficult acute limb ischemia cases with an endovascular-first approach using Lightning Bolt 7...
This advertorial is sponsored by Penumbra, Inc.
Adam Reichard, MD, discusses the use of Lightning Bolt 7® computer-assisted vacuum thrombectomy (CAVTTM) as a first-line option...
Surmodics announces early results from PROWL registry of Pounce thrombectomy system
Surmodics has announced that early results of a subset of 60 real-world acute, subacute, and chronic limb ischaemia patients from its PROWL registry study...
TCT 2024: PEERLESS trial finds large-bore mechanical thrombectomy superior for intermediate-risk PE
Findings from the first international randomised controlled trial (RCT) to compare patient outcomes following treatment with large-bore mechanical thrombectomy (LBMT) versus catheter-directed thrombolysis (CDT)...
Pounce Thrombectomy Platform use in acute limb ischemia: Vascular surgeons weigh in
This advertorial is sponsored by Surmodics.
Interventions for acute limb ischemia (ALI) represent up to 16% of the case volume for vascular surgeons and cost...
Surmodics receives FDA 510(k) clearance for Pounce XL thrombectomy system
Surmodics has announced that it has received Food and Drug Administration (FDA) 510(k) clearance for its Pounce XL thrombectomy system.
The Pounce system is indicated...
Argon Medical announces launch of peripheral venous thrombectomy system
Argon Medical has today announced the launch of the Cleaner Vac thrombectomy system for the removal of blood clot from the peripheral venous vasculature.
The...
First-in-human study of SonoThrombectomy system completed
SonoVascular has announced the successful initiation of its first-in-human study (FIH) of the company's SonoThrombectomy system, an ultrasound-facilitated, thrombolytic-enhanced platform that utilizes multiple mechanisms...
Lightning Bolt 7 ‘stands alone’ in aspiration thrombectomy for acute limb ischemia
This advertorial is sponsored by Penumbra, Inc.
“Honestly, there’s nothing even close to it for thrombectomy on the arterial side of things,” according to Martyn...
Novel ultrasound-facilitated thrombectomy with microbubbles shows promise in acute porcine model for DVT treatment
Evaluation of the safety and performance of a novel pharmaco-mechanical procedure for acute deep vein thrombosis (DVT) in two pigs demonstrated a significant reduction...
First-in-human study of Pounce thrombectomy system in acute iliofemoral DVT demonstrates 12-month PTS rate...
Twelve-month outcomes from the Pounce venous thrombectomy system (Vetex Medical) first-in-human study evaluating its use in the treatment of acute iliofemoral deep vein thrombosis...
Mechanical thrombectomy demonstrates superior outcomes to anticoagulation in DVT patients, analysis of RCT and...
Mechanical thrombectomy using the ClotTriever device (Inari Medical) for iliofemoral deep vein thrombosis (DVT) was found to be “associated with significantly” lower Villalta scores...
Large administrative databases enter crosshairs as comparative analysis shows percutaneous mechanical thrombectomy as superior...
The pitfalls of large administrative databases came to the fore during the presentation of a propensity-match scoring analysis demonstrating that percutaneous mechanical thrombectomy (MT)...
FDA approves ENGULF US pivotal trial of Hēlo thrombectomy system
Endovascular Engineering (E2) has announced US Food and Drug Administration (FDA) investigational device exemption (IDE) approval for its ENGULF US pivotal trial.
The study will...
Computer-assisted vacuum thrombectomy system for patients with pulmonary embolism demonstrates ‘rapid, statistically significant’ improvement...
Patients undergoing computer-assisted vacuum thrombectomy with the Indigo Aspiration System (Penumbra) for pulmonary embolism (PE) showed 2.7% rates of both major adverse events (MAEs)...
Akura thrombectomy system for PE appears safe and demonstrates reduction of RV/LV ratio in...
Results from a first-in-human, prospective, single-arm study of the Akura Medical thrombectomy system (Akura Medical) for pulmonary embolism (PE) were revealed this week at...
REAL-PE demonstrates statistically significant lower major bleeding rates with Ekos system compared to mechanical...
Data from the REAL-PE study were presented this week at TCT 2023 (23–26 October, San Francisco, USA) demonstrating that patients treated for pulmonary embolism...
Behind the procedure: Removing in-stent thrombosis with the RevCore Thrombectomy Catheter
This advertorial is sponsored by Inari Medical.
For patients with in-stent thrombosis (IST), one of the most critical unmet needs has been an effective method...
JETi registry provides “remarkable results” for peripheral thrombectomy system
Presenting “remarkable results” from the JETi registry—a prospective, multicenter, observational study which collected real-world data on the safety, performance and clinical benefits of the...
ACC 2023: Large bore mechanical thrombectomy reduces adverse outcomes in high-risk PE patients
Large bore mechanical thrombectomy with the FlowTriever system (Inari Medical) in patients with high-risk pulmonary embolism (PE) was associated with a significantly lower occurrence...
Penumbra launches Lightning Flash mechanical thrombectomy system
Penumbra have announced the Food and Drug Administration (FDA) clearance and launch of its Lightning Flash mechanical thrombectomy system.
“Lightning Flash features Penumbra’s novel Lightning intelligent...
Mechanical thrombectomy for DVT: Randomized data needed to boost growing evidence base
Two datasets presented during the late-breaking clinical trials session at The VEINS (Venous Endovascular Interventional Strategies) 2022 (Oct. 30–31) in Las Vegas—the latest results...
Surmodics announces successful first patient use of Pounce thrombectomy system
Surmodics has announced that J. Michael Bacharach, MD, a vascular interventionalist/cardiologist at North Central Heart, a division of Avera Heart Hospital in Sioux Falls,...
Surmodics builds thrombectomy portfolio with acquisition of Vetex Medical
Surmodics recently announced that it has acquired privately-held Vetex Medical Limited, expanding the company's thrombectomy portfolio with a second Food and Drug Administration (FDA) 510(k)-cleared...
Vetex Medical announces positive one-year outcomes for ReVene thrombectomy catheter
Vetex Medical has announced positive one-year outcomes from a European clinical study of the ReVene thrombectomy catheter. In patients with iliofemoral vein thrombus, the...
QuickClear mechanical thrombectomy system: A powerfully simple and effective solution
This video is sponsored by Philips.
Craig Walker, MD, of Houma, Louisiana; Bryan Fisher, MD, of Nashville, Tennessee; and Andre Biuckians, MD, of Towson, Maryland,...
Study finds racial disparities in acute stroke thrombectomy management
A new study has found several racial disparities after mechanical thrombectomy for stroke with respect to post-procedure management and outcomes. Vineeth Thirunavu of Northwestern...
Stent maintenance: Sustaining long-term patency in deep venous system
This advertorial is sponsored by Stryker/Inari Medical.
As venous stenting becomes more common, the focus must now shift to what occurs after the procedure, according...
SYMPHONY-PE trial demonstrates positive efficacy, efficiency, and safety results
Imperative Care has announced efficacy and safety results from the pivotal SYMPHONY-PE trial evaluating the company’s Symphony thrombectomy system in the treatment of acute...
Advances in endovascular therapy help drive innovative CPVI training course
The SVS Complex Peripheral Vascular Interventions (CPVI) Skills Course has become a fixture on the vascular surgery calendar over the past couple of years....
THRIVE study demonstrates a CAVT-first approach lends itself to better outcomes when compared to...
The THRIVE study - which shows that computer-assisted vacuum thrombectomy (CAVT™) is associated with reduced related readmissions and complication rates in the management of...
Analysis of BEST-CLI, PREVENT III reveals significant improvement in vein bypass outcomes over 20-year...
A post-hoc comparison of the BEST-CLI and PREVENT III multicenter, prospective, randomized controlled trials (RCTs) aimed at evaluating outcomes of vein bypass in chronic...
Penumbra’s STORM-PE randomized trial completes enrollment
Penumbra has announced the completion of enrollment in the STORM-PE clinical trial.
The pivotal, prospective, multicenter randomized controlled trial enrolled 100 patients to evaluate computer...
New THRIVE data on CAVT technology for acute limb ischemia show ‘fewer complications, hospital...
Recent THRIVE study data show that Penumbra’s computer-assisted vacuum thrombectomy (CAVT) technology not only has the potential to improve outcomes for lower extremity acute...
One-year TAMBE data highlight low mortality, importance of renal branch assessment
The four-branch Gore Excluder thoracoabdominal branch endoprosthesis (TAMBE) device demonstrated low mortality at one year with renal artery occlusion being the predominant device-related event...
Experts to examine ‘evolving landscape’ of vascular intervention in PE management
A number of topics relating to pulmonary embolism (PE) management—including lytic therapy versus thrombectomy, risk stratification and device selection—will feature this afternoon during an...
Imperative Care announces completion of enrollment in the SYMPHONY-PE study
Imperative Care has announced the completion of patient enrollment in its SYMPHONY-PE study, a pivotal investigational device exemption (IDE) trial evaluating the safety and...
Stryker completes acquisition of Inari Medical
Stryker announced today that it has completed the acquisition of Inari Medical. A press release notes that the addition of Inari brings an established...
Akura Medical enrols first patient in QUADRA-PE study
Akura Medical has announced today the first patient enrolment in the QUADRA-PE study evaluating the Katana thrombectomy system in patients with acute pulmonary embolism...
Penumbra launches Element vascular access system for VTE
Penumbra recently announced the launch of its Element vascular access system. This is the first laser-cut hypotube sheath designed for venous thromboembolism (VTE), the...
The endovascular revolution and open aortic training: ‘It’s not necessarily a crisis but it...
Jean Panneton, MD, considers himself what he terms a “blue-collar” vascular surgeon as much as one engaged in academic practice and the necessity of...
Positive one-year data for new venous valve portends promising future in chronic venous insufficiency...
SAVVE trial principal investigators discuss results showing 98.4% VenoValve device patency, 85% clinically meaningful benefit and an 80% rate of ulcer size reduction at...
Research suggests arm vein is the best alternative bypass conduit to GSV in patients...
A new analysis has found arm vein to be the most suitable alternative conduit to great saphenous vein (GSV) in chronic limb-threatening ischemia (CLTI)...
The top 10 most popular Vascular Specialist stories of October 2024
In October, the most read stories from Vascular Specialist included a new leadership announcement from the American College of Surgeons (ACS); study results examining a...
New analysis shows patients treated with Penumbra’s CAVT technology for PE utilize fewer hospital...
Penumbra has announced new data that demonstrate patients with intermediate-risk pulmonary embolism (PE) treated with Penumbra's computer-assisted vacuum thrombectomy (CAVT) technology have a shorter...
VenaCore device offers long-awaited interventional solution for challenging venous occlusions
This advertorial is sponsored by Inari Medical.
Despite the recent growth in mechanical thrombectomy devices for acute deep vein thrombosis (DVT), interventional options for wall...
Laser atherectomy redefined: Breakthrough 355nm technology opens next frontier in treatment
In this supplement, sponsored by AngioDynamics:
The storied history behind the Auryon Atherectomy System
What micro-CT reveals about the effectiveness of the Auryon laser...
Lightning Bolt 7 technology sets the pace for clot removal
NOTE: This video is ONLY available to watch in selected countries and geographies
Jean Bismuth, MD, the University of South Florida Health and Tampa General...
One-year STRIDE study data show ‘meaningful’ limb salvage, mortality and QoL outcomes
One-year outcomes from the STRIDE study of the Indigo aspiration thrombectomy system (Penumbra) for lower-extremity acute limb ischemia (ALI) showed target limb salvage and...
SOOVC outlines strides made to provide platform for surgeons conducting research in the OBL
The SVS sub-section on Outpatient and Office Vascular Care (SOOVC) Chair Anil Hingorani, MD, used the group’s dedicated VAM 2024 session to focus on...
Unmet needs and paradigm shifts: VESS scientific sessions set to plumb the vasculature for...
Selected research to be presented during the Wednesday afternoon, June 19, series of Vascular and Endovascular Surgery Society (VESS) Scientific Sessions (from 1:30 p.m....
Aspirex achieves 78% two-year primary patency rate in P-MAX postmarket observational study
At the Leipzig Interventional Course (LINC) 2024 (28–31 May, Leipzig, Germany), Michael Lichtenberg (Arnsberg Vascular Clinic, Arnsberg, Germany) shared for the first time a...
The top 10 most popular Vascular Specialist stories of April 2024
In April, the most read stories from Vascular Specialist include new research on Chat generative pre-trained transformer (GPT) technology and its application within vascular...
Penumbra announces FDA clearance of Lightning Flash 2 for the treatment of PE
Penumbra has announced the US Food and Drug Administration (FDA) clearance and launch of Lightning Flash 2, the next generation computer assisted vacuum thrombectomy (CAVT)...
FlowTriever device found to dramatically improve breathing among intermediate-risk acute pulmonary embolism patients
SCVS 2024 saw Zachary AbuRahma, DO, an assistant professor of vascular surgery at West Virginia University and the Charleston Area Medical Center in Charleston,...
New data show single-session Indigo aspiration system without overnight thrombolytics is safe and effective...
During the Society of Interventional Radiology (SIR) 2024 annual meeting (23–28 March, Salt Lake City, USA), newly presented data from a subgroup analysis of...
Study hints at long-term cost-effectiveness of CDT and PMT over oral anticoagulation for moderate...
During a presentation at the 2024 European Vascular Course (EVC; March 3–5) in Maastricht, The Netherlands, Anna Pouncey, MD, a clinical research fellow for...
Tackling DVT head on: Single-session, wall-to-wall thrombus removal with the ClotTriever BOLD
This advertorial is sponsored by Inari Medical.
Several years ago, when Nicolas Mouawad, MD, division chief of vascular surgery at McLaren Health in Bay City,...
CLOUT registry: Interim two-year rates of PTS ‘significantly lower’ than those in historical DVT...
Rates of post-thrombotic syndrome (PTS) among deep vein thrombosis (DVT) patients treated with the ClotTriever thrombectomy system (Inari Medical) who are logged in the...
JVS group open-access papers
The Journal of Vascular Surgery (JVS) editors announced the open-access articles available in the flagship title’s March 2024 issue.
The relevant papers are: “Creating hemodialysis...
Enrollment complete in APEX-AV study of mechanical aspiration system for acute PE
Patient enrollment is now complete in the APEX-AV trial evaluating the safety and efficacy of the AlphaVac F1885 (AngioDynamics) multipurpose mechanical aspiration system for...
The top 10 most popular Vascular Specialist stories of November 2023
In November, the most read stories from Vascular Specialist include a reassessment of which carotid revascularization treatment modality is best after the recent Centers...
One-year CLOUT data demonstrate low rate of PTS following treatment with ClotTriever
David Dexter (Sentara Vascular Specialists, Norfolk, USA) shared one-year data from the CLOUT registry this week at The VEINS 2023 (28–30 October, Las Vegas,...
EVS 2023: New data chart underrepresentation of women at the head of national clinical...
The underrepresentation of women vascular surgeons in national clinical trial leadership formed the central theme of data coming out of a new study that...
Financial viability, appropriate use and patient safety in the operation of outpatient facilities
The number of office-based facilities has been increasing steadily over the past several years—and more vascular surgeons may be considering becoming involved in operating...
Learn the who, the when and the what of treating deep vein thrombosis
Between additional available therapies, multiple new devices now on the market and evolving research supporting thrombus removal, Patrick Muck, MD, and Madhavi Meka, MD,...
VAM 2023: Learn at lunchtime
The Society for Vascular Surgery has added four lunchtime learning sessions to the VAM opening day.
Topics are both clinical and non-clinical, ranging from planning...
BASIL-2 and BEST-CLI: A tale of two limb trials
Optimal treatment of patients with chronic limb-threatening ischemia (CLTI) has been an ongoing debate within the vascular community, fueled by growing numbers of patients,...
FLAME, FLASH and ongoing PEERLESS trials collect ‘compelling’ data for FlowTriever device
Speaking on the FLAME, FLASH and PEERLESS trials that each collected data on the FlowTriever (Inari Medical) device for the treatment of pulmonary embolism...
A call to arms: Reuse of mature venous conduits urged
“Recycle that vein!”—that was the appeal from the authors of a new study that trialled the explantation of mature arteriovenous fistulas (AVFs) from patients...
RESCUE trial shows reduction in segmental and main pulmonary artery occlusions
Robert A. Lookstein, MD, who is executive vice chair, Diagnostic, Molecular and Interventional Radiology at the Icahn School of Medicine at Mount Sinai Hospital...
AVF 2023: One-year analysis of CLOUT registry reveals ‘significant and sustained’ long-term clinical improvements
Interim one-year outcomes from the multicenter, prospective, single-arm CLOUT registry investigating use of the ClotTriever thrombectomy system in all-comer patients with deep vein thrombosis...
First patient enrolled in DEFIANCE trial of the ClotTriever system in DVT
Inari Medical announced that the first patient has been enrolled in DEFIANCE, a prospective randomized controlled trial (RCT) comparing the clinical outcomes of patients...
SVS 10-year research goals: Why create research priorities?
As was the case with the 2011 set, researchers hope the updated priorities will serve as a starting point to align research efforts within...
SVS weighs in on 2023 Medicare payment rules for physicians and hospital outpatient services
The Society for Vascular Surgery (SVS) has submitted comment letters in response to the proposed rules issued by the Centers for Medicare and Medicaid...
Aortobifemoral grafting in the endovascular era: An exploration of the open procedure and its...
Aortobifemoral grafting for aortoiliac occlusive disease (AIOD) probably remains “very safe” in the era of endovascular repair, according to the senior author behind a...
Clinical outcomes of the ClotTriever system in DVT set to be evaluated in RCT
Inari Medical has announced planned enrollment of the DEFIANCE randomized controlled trial (RCT), which is designed to compare the clinical outcomes of patients with...
Tying healthcare waste and spending to productivity incentives
A 74-year-old woman was recently hospitalized for a pulmonary embolus from acute deep vein thrombosis (DVT) of the mildly edematous left lower leg. She...
AngioDynamics announces FDA clearance of expanded indications for Auryon atherectomy system
AngioDynamics recently announced receiving Food and Drug Administration (FDA) 510(k) clearance of an expanded indication for the Auryon atherectomy system to include arterial thrombectomy.
The FDA recently...
Vascular Live: Variety of vascular concerns on the slate
Be sure to save time for the Vascular Live theater-in-the-round presentations in the Exhibit Hall at the 2022 Vascular Annual Meeting (VAM) in Boston....
The top 10 most popular Vascular Specialist stories in April 2022
The digital version of the April 2022 issue of Vascular Specialist, the most recent editorial by our medical editor focusing on diversity within the...
AVF 2022: Six-month CLOUT data indicate ClotTriever can effectively remove full spectrum of thrombus
Six-month outcomes from the ongoing CLOUT registry demonstrate the “safety and efficacy” of the ClotTriever thrombectomy system in a real-world deep vein thrombosis (DVT)...
First patient enrolled in PEERLESS study of FlowTriever system
Inari Medical has announced that the first patient has been enrolled in PEERLESS prospective, randomized controlled trial (RCT) comparing the outcomes of patients with...
Learn by doing at February SVS PAD workshop
The Society for Vascular Surgery (SVS) Peripheral Arterial Disease (PAD) Workshop in February will feature four hours of hands-on surgical skills training, on 10...
Benefits of percutaneous fistula creation further bolstered by five-year Ellipsys data
The Ellipsys vascular access system (Avenu Medical/Medtronic) can be used to easily and safely create durable percutaneous arteriovenous fistulas (pAVFs) for haemodialysis—with new, long-term...
Registry data show greater clot chronicity on post-procedure inspection than initially predicted
Nearly half of patients deemed pre-procedurally to be suffering an acute case of deep vein thrombosis (DVT) turned out to have a “much more”...
First pulmonary embolism patient enrolled in FLAME study
Inari Medical has announced the enrollment of the first high-risk pulmonary embolism (PE) patient in the FLAME (FlowTriever for acute massive pulmonary embolism) study....
Vascular surgery COVID-19 registry participants probe state of practice amid winter surge
The question of the COVID-19 pandemic’s effect on vascular practice continues to occupy members of the specialty. Contributors to a global vascular surgery registry...
Straub Medical announces first patient treated in US with Rotarex S atherectomy device
Straub Medical, the US direct-sales subsidiary of Swiss outfit Straub Medical AG, has announced the launch and first intervention performed with the Rotarex S...
The PERT Movement – Vascular surgeons must answer the call
Pulmonary embolism (PE) is the third most common cause of cardiovascular death in the United States and remains the most common preventable cause of...
Schedule-At-A-Glance
Wednesday, June 8
6:00 a.m. – 6:30 p.m.
Registration
7:00 – 10:00 a.m.
Postgraduate Courses
P1: Controversies and Management of Lower Extremity Arterial Occlusive Disease
P2: Complete Management of Venous...
From the editor: New column launches
This month we are introducing a new feature in Vascular Specialist – a column on medicolegal matters. After all there are few issues that...
Keep RUC in mind
In July, the Society for Vascular Surgery sent requests to its members to complete surveys regarding the work involved with creation, revision, and thrombectomy...
